KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to -$667.0 million.

  • AbbVie's Interest & Investment Income fell 1285.96% to -$667.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.6 billion, marking a year-over-year decrease of 3392.12%. This contributed to the annual value of -$2.2 billion for FY2024, which is 2826.6% down from last year.
  • AbbVie's Interest & Investment Income amounted to -$667.0 million in Q3 2025, which was down 1285.96% from -$678.0 million recorded in Q2 2025.
  • AbbVie's Interest & Investment Income's 5-year high stood at -$378.0 million during Q4 2023, with a 5-year trough of -$678.0 million in Q2 2025.
  • Its 5-year average for Interest & Investment Income is -$539.2 million, with a median of -$539.0 million in 2022.
  • As far as peak fluctuations go, AbbVie's Interest & Investment Income skyrocketed by 2058.82% in 2023, and later crashed by 6137.57% in 2024.
  • Over the past 5 years, AbbVie's Interest & Investment Income (Quarter) stood at -$571.0 million in 2021, then grew by 16.64% to -$476.0 million in 2022, then increased by 20.59% to -$378.0 million in 2023, then plummeted by 61.38% to -$610.0 million in 2024, then fell by 9.34% to -$667.0 million in 2025.
  • Its Interest & Investment Income was -$667.0 million in Q3 2025, compared to -$678.0 million in Q2 2025 and -$627.0 million in Q1 2025.